Back to Search
SAMIT HIRAWAT, M.D.
M.D.
Medical Oncology Physician
NPI: 1619102878Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
25MA07813100(NJ)
Research & Publications (9)
Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers.
PMID 17389552·J Clin Pharmacol·2007
3-trial
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.
PMID 18722008·Lancet·2008
3-trial
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model.
PMID 18272502·Proc Natl Acad Sci U S A·2008
7-preclinical
PTC124 targets genetic disorders caused by nonsense mutations.
PMID 17450125·Nature·2007
7-preclinical
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors.
PMID 16819636·Cancer Chemother Pharmacol·2007
3-trial
The androgen receptor: structure, mutations, and antiandrogens.
PMID 12901287·Cancer Invest·2003
6-review
Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: a promising treatment.
PMID 11279631·Am J Hematol·2001
5-case
Talc induced transfusion independence in a patient with myelodysplasia.
PMID 11226524·Leuk Res·2001
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5 BUXTON RD
CHATHAM, NJ 07928 - Phone
- (973) 701-0808
Quick Facts
- NPI
- 1619102878
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile